Drug Details: SERPASIL-ESIDRIX #1

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Drug Details

Drug Name:	SERPASIL-ESIDRIX #1
FDA Application No:	(NDA) 011878
Active Ingredient(s):	HYDROCHLOROTHIAZIDE; RESERPINE
Company:	NOVARTIS
Chemical Type:	4 New combination
Review Classification:	S Standard review drug

There are no Therapeutic Equivalents	Labels are not available
Approval History and Related Documents are not available

You can see the products in the same application. The table can be sorted by clicking the header columns.

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code
SERPASIL-ESIDRIX #1	HYDROCHLOROTHIAZIDE; RESERPINE	25MG; 0.1MG	TABLET; ORAL	Discontinued	No	None
SERPASIL-ESIDRIX #2	HYDROCHLOROTHIAZIDE; RESERPINE	50MG; 0.1MG	TABLET; ORAL	Discontinued	No	None

Comments for SERPASIL-ESIDRIX #1

Name: *

Email: *

Text:
(HTML OK)

Enter the code from the picture: *
(click here to load another image)

There are no comments.